Or if you're already a Pharma IQ member, sign in below to download. Sign In Join
The FDA Final Rule on UDIs is a critical move forward in utilising and leveraging technology to advance medical device information. In this exclusive interview Dawn Fowler, Sr. Manager, Labeling & Documentation at Endologix, speaks to Andrea Charles from Pharma IQ, about the importance of real world assessment in executing UDI programs and reveals scalable ways to implement unique identifiers for medical devices. Fowler also shares her top 3 tips for implementing UDI Information on a medical device and insights into the common pitfalls manufacturers make when they are just setting out.
Beyond just compliance and the immediate impact on traceability, Fowler discusses the gains in supply chain efficiencies to be made by implementing a UDI, and the investments she has seen in new technologies by hospitals and other supply chain stakeholders.
Have Your Say
Rate this feature and give us your feedback in the comments section below